Valeant Pharmaceuticals International, Inc. (VRX): Debt Offering News

VRX – Prices priced its previously announced offering of 9.250% senior notes due 2026.

Key Facts Surrounding This News Item

  • VRX had a POWR Rating of D (Sell) coming into today.
  • VRX was 0.25% above its 10-Day Moving Average coming into today.
  • VRX was -7.77% below its 20-Day Moving Average coming into today.
  • VRX was -18.47% below its 50-Day Moving Average coming into today.
  • VRX was -10.78% below its 100-Day Moving Average coming into today.
  • VRX was -2.40% below its 200-Day Moving Average coming into today.
  • VRX had returned -24.01% year-to-date leading up to today’s news, versus a +4.37% return from the benchmark S&P 500 during the same period.

More Info About Valeant Pharmaceuticals International, Inc. (VRX)

Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada. View our full VRX ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

VRX at a Glance

VRX Current POWR Rating™
Overall POWR Rating™
VRX Current Price $24.64 1.65%
More VRX Ratings, Data, and News

VRX Price Reaction

The day of this event (Mar. 13, 2018)
VRX Closing Price$16.08 1.84%
VRX Volume8,596,100
51.21% from avg
Leading up to this event
VRX 1-mo return12.03%
After this event
VRX 1-day return6.84%
VRX 3-day return5.62%
VRX 5-day return1.19%

VRX Price Chart

More Valeant Pharmaceuticals International, Inc. (VRX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VRX News
Page generated in 1.0411 seconds.